A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
Rachel M. Presti(Johns Hopkins University), Edgar T. Overton(University of Alabama at Birmingham), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Jason M. Brenchley(Office of Extramural Research), Douglas Kitch(Cancer Research And Biostatistics), Alan Landay(The University of Texas Medical Branch at Galveston), Eunice Yeh(Cancer Research And Biostatistics), Adriana Andrade(Johns Hopkins University), Jeffrey M. Jacobson(Drexel University), Michael P. Dubé(University of Southern California), Netanya S. Utay(The University of Texas Southwestern Medical Center), Cara C. Wilson(University of Colorado Anschutz Medical Campus), Karin L. Klingman(National Institutes of Health), Amanda H. Loftin(National Institute of Allergy and Infectious Diseases), Jacob D. Estes(Oregon National Primate Research Center), Brett Williams(Rush University Medical Center), Jacob K. Flynn(National Institute of Allergy and Infectious Diseases)
Cited by 19
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
|The Journal of Experimental Medicine|2004|1.8k
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
|Nature Medicine|2009|1.7k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
HIV preferentially infects HIV-specific CD4+ T cells
|Nature|2002|1.3k